LAURUSLABS

Laurus Labs Share Price

 

 

Invest in Laurus Labs with 3.24X leverage

Invest with MTF
Laurus Labs live price: ₹1042.9. It opened at ₹1,028 vs previous close ₹1,039; intraday high/low: ₹1,050/₹994. The 50 & 200 DMA stand at ₹1,013.30/₹922.12.

Laurus Labs Performance

  • Today's Low
  • ₹994
  • Today's High
  • ₹1,050
  • 52 Week Low
  • ₹518
  • 52 Week High
  • ₹1,141
  • Open Price₹1,028
  • Previous Close₹1,039
  • Volume2,919,766
  • 50 DMA₹1,013.30
  • 100 DMA₹995.16
  • 200 DMA₹922.12

Investment Returns

  • Over 1 Month -2.08%
  • Over 3 Month -5.75%
  • Over 6 Month + 19.6%
  • Over 1 Year + 71.23%

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 66.8
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 56,302
  • P/B Ratio
  • 11.1
  • Average True Range
  • 38.48
  • EPS
  • 15.62
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -6.3
  • RSI
  • 55.51
  • MFI
  • 27.05

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹1,042.90
+ 4.1 (0.39%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,010.08
  • 50 Day
  • ₹1,013.30
  • 100 Day
  • ₹995.16
  • 200 Day
  • ₹922.12

Resistance and Support

1028.98 Pivot Speed
  • R3 1,119.27
  • R2 1,084.53
  • R1 1,063.72
  • S1 1,008.17
  • S2 973.43
  • S3 952.62

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 6,721.63 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 9% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 90 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 41 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-23 Quarterly Results
2025-10-23 Quarterly Results & Interim Dividend
2025-07-25 Quarterly Results
2025-04-24 Audited Results & Interim Dividend
2025-01-24 Quarterly Results
Date Purpose Remarks
2025-10-31 INTERIM Rs.0.80 per share(40%)Interim Dividend
2025-05-09 INTERIM Rs.0.80 per share(40%)Second Interim Dividend
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
View Laurus Labs Dividend History Arrow

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.49%
9.49%
1.52%
26.52%
0%
22.64%
12.34%

Laurus Labs FAQs

Laurus Labs share price is ₹1,042 As on 04 April, 2026 | 00:03

The Market Cap of Laurus Labs is ₹56301.6 Cr As on 04 April, 2026 | 00:03

The P/E ratio of Laurus Labs is 66.8 As on 04 April, 2026 | 00:03

The PB ratio of Laurus Labs is 11.1 As on 04 April, 2026 | 00:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23